
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67409
Internal Medicine
Nephrology
From Smoothies to Dialysis: The Impact of Oxalate Nephropathy
Muacevic Alexander
Adler John R
Samra Mohammed 1
Gupta Isha 234
1 Health Sciences, University of Debrecen, Debrecen, HUN
2 Nephrology, Middletown Medical, Middletown, USA
3 Nephrology, Garnet Health Medical Center, Middletown, USA
4 Internal Medicine/Nephrology, Touro College of Osteopathic Medicine, Middletown, USA
Mohammed Samra drmosamra@gmail.com
21 8 2024
8 2024
16 8 e6740921 8 2024
Copyright © 2024, Samra et al.
2024
Samra et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/281970-from-smoothies-to-dialysis-the-impact-of-oxalate-nephropathy
Oxalate nephropathy is a rare cause of acute kidney injury that can lead to end-stage renal disease. This case report describes a 54-year-old male with type 2 diabetes mellitus and chronic kidney disease who presented for a routine clinic follow-up. Laboratory tests revealed significant deterioration in renal function with an unrevealing history and symptoms suggestive of the process. Initial investigations for worsening renal function were inconclusive, prompting a renal biopsy that confirmed acute tubular injury with abundant calcium oxalate deposits. Further investigation into dietary history revealed that the patient regularly consumed high-oxalate foods, such as spinach and kale smoothies, under the impression they were beneficial for his diabetes. Despite the initiation of hemodialysis, the patient did not recover renal function and remains dialysis-dependent. This case underscores the need for a high index of suspicion for oxalate nephropathy in chronic kidney disease patients presenting with unexplained acute kidney injury. Diagnosis is confirmed through renal biopsy and should be considered in patients with relevant dietary histories.

chronic hemodialysis
oxalate crystals
kidney biopsy
acute kidney injury
end stage renal disease
secondary oxalate nephropathy
==== Body
pmcIntroduction

Oxalate nephropathy (ON) is a disease that affects the renal tubules and is characterized by the deposition of calcium oxalate crystals in the renal parenchyma [1,2]. ON is a rare yet significant cause of acute kidney injury (AKI), which most often progresses to end-stage renal disease (ESRD) [3]. ON can arise either from primary hyperoxaluria or from secondary causes of hyperoxaluria [1].

Primary hyperoxaluria is a broad group of genetic disorders that involve enzymatic defects in the glyoxylate pathway, which leads to impaired oxalate metabolism and subsequent crystallization within the renal tubules [4].

Secondary hyperoxaluria is a more common cause of ON but is often underrecognized [5]. Many factors are associated with its development [6]. The factors include but are not limited to increased intestinal absorption of oxalate, nutritional deficiencies, reduced fluid intake, impaired renal excretion, and a high oxalate diet [7,8].

The clinical presentation of ON varies between patients, and its diagnostic criteria remain insufficiently defined, underscoring the importance of increased clinical awareness for effective recognition and management to prevent irreversible renal damage [9].

Here, we report a case of a dialysis requiring ESRD caused by biopsy-proven acute ON.

Case presentation

A 54-year-old male with a history of type 2 diabetes mellitus (T2DM) with diabetic retinopathy and chronic kidney disease (CKD) stage 3A was seen in the nephrology clinic for a follow-up regarding abnormal kidney function tests. Repeat laboratory testing performed at the clinic showed blood urea nitrogen (BUN) 125 mg/dl (baseline 37 mg/dl), creatinine 8.6 mg/dl (baseline 1.7 mg/dl), estimated glomerular filtration rate (eGFR) 6.8 ml/min/1.73 m2 (baseline 45 ml/min/1.73 m2) (Table 1). His glycated hemoglobin (HbA1c) was at 5%, similar to previous readings. On physical examination, no significant findings were noted. The patient reported feeling healthy, denied any episodes of diarrhea or vomiting, and confirmed no use of new medications or non-steroidal anti-inflammatory drugs (NSAIDs). Subsequently, the patient was admitted to the hospital and an extensive renal workup was initiated for evaluation of his AKI on CKD.

Table 1 Lab values of the patient prior to admission

BUN: blood urea nitrogen; eGFR: estimated glomerular filtration rate; PTH: parathyroid hormone; HbA1c: glycated haemoglobin

Test	Result	Baseline (3 months ago)	Normal Hospital Range	
BUN	125 mg/dL	 37 mg/dL	7-20 mg/dL	
Creatinine	8.6 mg/dL	 1.7 mg/dL	0.6-1.3 mg/d	
eGFR	6.8 mL/min/1.73 m²	 45 mL/min/1.73 m²	>60 mL/min/1.73 m²	
Albumin Creatinine Ratio	 >300 mg/g	 <30 mg/g	<30 mg/g	
Intact PTH	 724 pg/mL	 150 pg/mL	10-65 pg/mL	
Calcium	 7.7 mg/dL	 9 mg/dL	8.5-10.2 mg/dL	
Phosphorus	 7.8 mg/dL	 3.5 mg/dL	2.5-4.5 mg/dL	
HbA1c	 5%	 5%	4-6%	
Hemoglobin	 9.9 g/dL	 13 g/dL	12-16 g/dL	
Hematocrit	 30%	 40%	36-48%	
Platelet	 125 x 10³/µL	 128 x 10³/µL	150-450 x 10³/µL	

The renal workup showed normal C3 and C4 levels and a negative antineutrophilic cytoplasmic antibody (ANCA) panel, anti-glomerular basement membrane (anti-GBM), and anti-myeloperoxidase (anti-MPO). A serological workup for hepatitis B virus, hepatitis C virus, and HIV was performed, and the results were negative. Further urine and serum electrophoresis showed no monoclonal gammopathy. In addition, noncontrast CT did not show any abnormalities (Figure 1). As these investigations failed to provide a definitive cause for the AKI, a renal biopsy was performed on Day 3 of hospital admission.

Figure 1 Coronal view of CT abdomen pelvis without IV contrast

On Day 4, there was no improvement in renal function and the patient was persistently azotaemic. Hence, it was decided that the patient would undergo hemodialysis. The biopsy report revealed abundant tubular calcium oxalate deposits (Figure 2). Electron microscopy revealed that numerous tubules contain calcium oxalate crystals along with PAS-positive hyaline casts. The interstitium contained interstitial inflammation composed of mononuclear cells. Approximately 40-50% of the renal cortex showed tubular atrophy and interstitial fibrosis. Arteries showed mild sclerosis and arterioles showed moderate sclerosis and hyalinosis. Diffuse flattening and loss of brush borders were also noted in the proximal tubular epithelium. Immunofluorescence microscopy was negative for paraprotein or immune complex deposition.

Figure 2 Renal histology under light microscopy at 30x magnification revealing abundant oxalate deposits

Green arrows highlight calcium oxalate deposits, forming intraluminal translucent crystals.

Based on these findings, a diagnosis was made of severe acute tubular injury with calcium oxalate deposits consistent with oxalate nephropathy superimposed upon moderate glomerulosclerosis, moderate tubular atrophy and interstitial fibrosis, and mild to moderate vascular sclerosis.

After reviewing the biopsy findings, a detailed dietary history was obtained from the patient’s sister. According to her, the patient used to daily consume a concoction of green leafy vegetables, which included spinach and kale, one orange, and a lemon. These foods are known to be high in oxalate, contributing significantly to dietary oxalate intake. In the absence of any other factors, this dietary habit could potentially explain the development of ON in the patient [10,11]. Unfortunately for the patient, his kidneys were not able to recover from this acute attack, and to date, he remains on hemodialysis.

Discussion

This case highlights the debilitating nature of oxalate crystal deposition in tubules. This relatively young patient, who had been stable with an eGFR of 45 ml/min/m2, suddenly had an acute tubular injury that caused him to progress to ESRD and become hemodialysis dependent. According to the literature, the prognosis for ON is poor and most cases progress to chronic kidney failure [12]. Higher serum creatinine levels at presentation and tubular atrophy are associated with worse prognosis [13].

The underdiagnosis of this disease often delays early suspicion and accurate diagnosis [14]. Renal biopsy is the gold standard for diagnosis; however, 24-hour urine oxalate measurements could also provide an insight albeit it being rarely performed outside of the setting of nephrolithiasis [15]. An interesting point to be noted in this case is the patient’s diet. The patient’s sister unknowingly blended foods high in oxalate into a smoothie and incorporated this into the patient’s diet for daily consumption, believing it to be a healthy choice for a diabetic. Given the history of this patient’s CKD and diabetes history, this dietary practice might have hindered oxalate excretion, potentially contributing to ON [16]. Whether CKD itself predisposes individuals to reduced urinary oxalate excretion remains uncertain [17].

The patient received counseling on appropriate rehydration and the importance of taking calcium supplements. Additionally, he was advised to follow a low-fat, low-oxalate diet and to avoid foods rich in vitamin C [18,19].

Conclusions

ON is a rare but critical disease that can rapidly progress to ESRD as depicted in this report. Our patient, who had suddenly deteriorated due to the long-term consumption of high-oxalate food, underscores the importance of carefully reviewing dietary history in CKD patients presenting with AKI. The elusiveness of the disease warrants heightened clinical awareness and timely diagnostic measures such as a renal biopsy. Early identification and intervention, including dietary modifications and patient education on oxalate-rich foods, are crucial in preventing irreversible renal damage and progression to ESRD. Further research is warranted to elucidate the interplay between CKD and oxalate metabolism, potentially paving the way for targeted preventive strategies and improved patient outcomes in this challenging condition.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Mohammed Samra, Isha Gupta

Acquisition, analysis, or interpretation of data:  Mohammed Samra, Isha Gupta

Drafting of the manuscript:  Mohammed Samra, Isha Gupta

Critical review of the manuscript for important intellectual content:  Mohammed Samra, Isha Gupta

Supervision:  Isha Gupta
==== Refs
References

1 Pathophysiology and management of hyperoxaluria and oxalate nephropathy: a review Am J Kidney Dis Demoulin N Aydin S Gillion V Morelle J Jadoul M 717 727 79 2022 34508834
2 Kidney oxalate crystal deposition in adult patients: a relatively common finding Clin Nephrol Yang Y Sharma PD Nair V 243 250 93 2020 32101518
3 Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts Transplant Rev (Orlando) Karaolanis G Lionaki S Moris D Palla VV Vernadakis S 182 187 28 2014 24999029
4 Primary hyperoxaluria N Engl J Med Cochat P Rumsby G 649 658 369 2013 23944302
5 Secondary oxalate nephropathy: a systematic review Kidney Int Rep Lumlertgul N Siribamrungwong M Jaber BL Susantitaphong P 1363 1372 3 2018 30450463
6 Food oxalate: factors affecting measurement, biological variation, and bioavailability J Am Diet Assoc Massey LK 1191 1194 107 2007 17604750
7 Oxalic acid and the hyperoxaluric syndromes Kidney Int Williams HE 410 417 13 1978 351269
8 Intestinal transport of an obdurate anion: oxalate Urol Res Hatch M Freel RW 1 16 33 2005 15565438
9 Etiologies, clinical features, and outcome of oxalate nephropathy Kidney Int Rep Buysschaert B Aydin S Morelle J Gillion V Jadoul M Demoulin N 1503 1509 5 2020 32954074
10 Acute oxalate nephropathy induced by oral high-dose vitamin C alternative treatment Clin Kidney J Poulin LD Riopel J Castonguay V Mac-Way F 218 7 2014 24944785
11 “Green smoothie cleanse” causing acute oxalate nephropathy Am J Kidney Dis Makkapati S D'Agati VD Balsam L 281 286 71 2018 29203127
12 Oxalate nephropathy and the mechanism of oxalate-induced kidney injury Kidney Dis (Basel) Bao D Wang Y Zhao MH 459 468 9 2023 38089442
13 Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease Clin Biochem Perinpam M Enders FT Mara KC 1014 1019 50 2017 28764885
14 The clinical and pathological characteristics of patients with oxalate nephropathy Kidney360 Llanos M Kwon A Herlitz L 65 72 5 2024 38095544
15 Enteric hyperoxaluria: an important cause of end-stage kidney disease Nephrol Dial Transplant Nazzal L Puri S Goldfarb DS 375 382 31 2016 25701816
16 Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity Curr Opin Nephrol Hypertens Efe O Verma A Waikar SS 316 320 28 2019 31045662
17 Urinary excretion of oxalate in renal failure Nephron Camici M Balestri PL Lupetti S Colizzi V Falcone G 269 270 30 1982 7099340
18 The management of patients with enteric hyperoxaluria Urolithiasis Asplin JR 33 43 44 2016 26645872
19 High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans Nephrol Dial Transplant Hess B Jost C Zipperle L Takkinen R Jaeger P 2241 2247 13 1998 9761503
